Integrated Filing — IndAS

General information about company
Scrip Code	544282
NSE Symbol	SAGILITY
MSEI Symbol	NOTLISTED
ISIN	INE0W2G01015
Name of company	Sagility India Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	14-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	06-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Business Process Management Services
Start date and time of board meeting	14-May-2025   18:45:00
End date and time of board meeting	14-May-2025   20:30:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2024-06-24
Indicate Company website link for updated RPT policy of the Company	https://sagilityhealth.com/wp-content/uploads/2024/06/Policy-on-Materiality-of-RPTs-and-dealing-with-RPTs.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
No default for the year ended 31 March 2025

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	4553540000	17166850000
	Other income	84990000	505030000
	Total income	4638530000	17671880000
2	Expenses
(a)	Cost of materials consumed	0	0
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	0	0
(d)	Employee benefit expense	2440940000	9358390000
(e)	Finance costs	226470000	932760000
(f)	Depreciation, depletion and amortisation expense	188020000	991750000
(f)	Other Expenses
1	Other expenses	688440000	2689480000
	Total other expenses	688440000	2689480000
	Total expenses	3543870000	13972380000
3	Total profit before exceptional items and tax	1094660000	3699500000
4	Exceptional items	0	0
5	Total profit before tax	1094660000	3699500000
6	Tax expense
7	Current tax	210440000	827560000
8	Deferred tax	66440000	157120000
9	Total tax expenses	276880000	984680000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	817780000	2714820000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	817780000	2714820000
17	Other comprehensive income net of taxes	45150000	-107060000
18	Total Comprehensive Income for the period	862930000	2607760000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	46792740000	46792740000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		44294820000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	0.17	0.59
	Diluted earnings (loss) per share from continuing operations	0.17	0.59
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	0.17	0.59
	Diluted earnings (loss) per share from continuing and discontinued operations	0.17	0.59
24	Debt equity ratio	0.001	0.001
25	Debt service coverage ratio	0.011	0.0145
26	Interest service coverage ratio	0.0666	0.0603
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	3176660000
	Capital work-in-progress	70000
	Investment property	0
	Goodwill	20993220000
	Other intangible assets	16530000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	78129740000
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	314810000
	Total non-current financial assets	78444550000
	Deferred tax assets (net)	990130000
	Other non-current assets	75930000
	Total non-current assets	103697090000
2	Current assets
	Inventories	0
	Current financial asset
	Current investments	0
	Trade receivables, current	8895970000
	Cash and cash equivalents	899440000
	Bank balance other than cash and cash equivalents	0
	Loans, current	0
	Other current financial assets	236390000
	Total current financial assets	10031800000
	Current tax assets (net)	0
	Other current assets	950410000
	Total current assets	10982210000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	114679300000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	46792740000
	Other equity	54904630000
	Total equity attributable to owners of parent	101697370000
	Non controlling interest
	Total equity	101697370000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	7441400000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	4460000
	Total non-current financial liabilities	7445860000
	Provisions, non-current	413700000
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	7859560000
	Current liabilities
	Current financial liabilities
	Borrowings, current	2920030000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	135140000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	601260000
	Total Trade payable	736400000
	Other current financial liabilities	787440000
	Total current financial liabilities	4443870000
	Other current liabilities	220760000
	Provisions, current	454040000
	Current tax liabilities (Net)	3700000
	Deferred government grants, Current	0
	Total current liabilities	5122370000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	12981930000
	Total equity and liabilites	114679300000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Unaudited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Re-measurement losses on defined benefit plans	-40270000	-50130000
	Total Amount of items that will not be reclassified to profit and loss	-40270000	-50130000
2	Income tax relating to items that will not be reclassified to profit or loss	-10140000	-12620000
3	Amount of items that will be reclassified to profit and loss
1	Change in fair value of derivatives designated as cash flow hedges (net) (A)	100870000	-91740000
	Total Amount of items that will be reclassified to profit and loss	100870000	-91740000
4	Income tax relating to items that will be reclassified to profit or loss	25590000	-22190000
5	Total Other comprehensive income	45150000	-107060000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Unaudited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			3699500000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			932760000
	Adjustments for decrease (increase) in inventories			0
	Adjustments for decrease (increase) in trade receivables, current			-590090000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			25930000
	Adjustments for decrease (increase) in other non-current assets			-50080000
	Adjustments for other financial assets, non-current			-56930000
	Adjustments for other financial assets, current			-130800000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			-374440000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			15100000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			991750000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			109720000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			286640000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			38100000
	Adjustments for dividend income			0
	Adjustments for interest income			96010000
	Adjustments for share-based payments			646700000
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			-104140000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			1644210000
	Net cash flows from (used in) operations			5343710000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			362640000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			4981070000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			13270000
	Purchase of property, plant and equipment			518600000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			3370000
	Dividends received			0
	Interest received			11680000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) investing activities	-490280000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			2489580000
	Payments of lease liabilities			401260000
	Dividends paid			0
	Interest paid			981810000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			71990000
	Net cash flows from (used in) financing activities			-3800660000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			690130000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			690130000
	Cash and cash equivalents cash flow statement at beginning of period			209310000
	Cash and cash equivalents cash flow statement at end of period			899440000